A new study has provided insights into an important biological mechanism that supports survival of aggressive, hard-to-treat cancers, and in the process, has uncovered fascinating new information about how cells divide and ...
Aug 30, 2023
0
11
A new form of screening may improve survival rates among people with a fast-growing type of brain tumor by helping identify those most likely to benefit from certain treatments.
Aug 22, 2023
0
7
A new study sheds light on the genetic messages encoded by genes within "triple-negative" breast cancers—and poses important questions on how they could be better treated in future.
Aug 14, 2023
0
1
New research, published in Nature Genetics, shows that more people may benefit from PARP inhibitor drugs, like olaparib, which are already used to treat some breast, ovarian and prostate cancer patients who have inherited ...
Aug 1, 2023
0
43
Scientists have unveiled the first and largest encyclopedia of protein alterations in soft tissue sarcomas—opening the door to a new era of understanding and treatment for this group of rare cancers, which account for around ...
Jul 31, 2023
0
22
Leiomyosarcoma is a type of soft tissue sarcoma that is hard to treat and associated with a poor prognosis. Scientists at the Institute of Cancer Research are working to better understand the biology of this cancer to develop ...
Jul 25, 2023
0
1
An international study has accurately categorized tumor and immune cells of non-human animal species by applying an artificial intelligence (AI) algorithm that was trained on human lung cancer samples.
Jun 30, 2023
0
37
Combining five existing drugs can keep a highly aggressive type of bone marrow cancer at bay for longer, an innovative trial has shown.
Jun 23, 2023
0
20
A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as effective as the next best treatment, according to interim results from a phase II study.
Jun 5, 2023
0
14
An innovative cancer drug discovered by scientists at The Institute of Cancer Research, London, is set to enter a new clinical trial.
May 5, 2023
0
3
